| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.533 | 0.012 | 0.533 | Vasodilator, coronary | 0.278 0.107 CID_131770039 | ||
| 0.507 | 0.014 | 0.507 | Hypoxia-inducible factor 1 alpha inhibitor | 0.221 0.128 CID_131770039 | ||
| 0.48 | 0.004 | 0.48 | 5 Hydroxytryptamine uptake inhibitor | 0.261 0.008 CID_131770039 | ||
| 0.501 | 0.028 | 0.501 | Calcium channel L-type activator | 0.388 0.089 CID_131770039 | ||
| 0.482 | 0.054 | 0.482 | Analgesic | 0.242 0.19 CID_131770039 | ||
| 0.389 | 0.004 | 0.389 | Adrenaline uptake inhibitor | 0.234 0.005 CID_131770039 | ||
| 0.419 | 0.1 | 0.419 | Caspase 9 stimulant | |||
| 0.338 | 0.034 | 0.338 | Psychostimulant | |||
| 0.292 | 0.03 | 0.417 | Dual specificity phosphatase inhibitor | 0.417 0.013 CID_131770039 | CID_131770039 | |
| 0.255 | 0.004 | 0.255 | Toll-Like receptor 3 antagonist | 0.199 0.006 CID_131770039 | ||
| 0.286 | 0.04 | 0.286 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.31 | 0.067 | 0.31 | Lipoxygenase inhibitor | |||
| 0.32 | 0.09 | 0.32 | Thioredoxin glutathione reductase inhibitor | |||
| 0.239 | 0.012 | 0.239 | Alpha 2 adrenoreceptor antagonist | |||
| 0.279 | 0.056 | 0.279 | Vasodilator | |||
| 0.262 | 0.043 | 0.262 | Peptidyltransferase inhibitor | 0.189 0.113 CID_131770039 | ||
| 0.302 | 0.09 | 0.302 | Calcium channel activator | |||
| 0.219 | 0.012 | 0.219 | Alpha 2a adrenoreceptor antagonist | |||
| 0.323 | 0.116 | 0.323 | 15-Lipoxygenase inhibitor | |||
| 0.2 | 0.008 | 0.2 | Inducible nitric-oxide synthase inhibitor | 0.179 0.011 CID_131770039 | ||
| 0.289 | 0.1 | 0.289 | Transcription factor NF kappa B inhibitor | |||
| 0.201 | 0.018 | 0.201 | Alpha 2c adrenoreceptor antagonist | |||
| 0.225 | 0.057 | 0.225 | DNA methyltransferase I inhibitor | |||
| 0.233 | 0.067 | 0.233 | Antimitotic | 0.218 0.075 CID_131770039 | ||
| 0.19 | 0.026 | 0.19 | Alpha 2b adrenoreceptor antagonist | |||
| 0.255 | 0.091 | 0.255 | Insulysin inhibitor | |||
| 0.188 | 0.025 | 0.188 | Antibacterial (Helicobacter pylori) | 0.136 0.059 CID_131770039 | ||
| 0.174 | 0.015 | 0.174 | Nitric-oxide synthase inhibitor | 0.138 0.028 CID_131770039 | ||
| 0.246 | 0.093 | 0.246 | Spasmolytic | |||
| 0.214 | 0.07 | 0.214 | DNA methylase inhibitor | |||
| 0.199 | 0.058 | 0.199 | Amyloid beta precursor protein antagonist | |||
| 0.235 | 0.097 | 0.235 | 5 Hydroxytryptamine release stimulant | |||
| 0.302 | 0.17 | 0.302 | Apoptosis agonist | |||
| 0.222 | 0.099 | 0.222 | DNA damaging | |||
| 0.155 | 0.034 | 0.155 | Antiadrenergic | |||
| 0.191 | 0.071 | 0.191 | P-glycoprotein inhibitor | |||
| 0.137 | 0.018 | 0.137 | Adrenaline agonist | |||
| 0.246 | 0.13 | 0.246 | Vasodilator, peripheral | |||
| 0.15 | 0.034 | 0.15 | Adrenaline antagonist | |||
| 0.121 | 0.01 | 0.121 | Beta adrenoreceptor antagonist | |||
| 0.227 | 0.124 | 0.227 | 12-Lipoxygenase inhibitor | |||
| 0.129 | 0.036 | 0.129 | Urease inhibitor | |||
| 0.153 | 0.061 | 0.153 | Toll-Like receptor 9 antagonist | |||
| 0.199 | 0.114 | 0.2 | Antioxidant | 0.2 0.114 CID_131770039 | CID_131770039 | |
| 0.106 | 0.025 | 0.106 | Alpha adrenoreceptor agonist | |||
| 0.13 | 0.051 | 0.13 | Microtubule formation inhibitor | |||
| 0.22 | 0.142 | 0.22 | Caspase 3 stimulant | |||
| 0.228 | 0.153 | 0.228 | Sodium/bile acid cotransporter inhibitor | 0.196 0.193 CID_131770039 | ||
| 0.091 | 0.019 | 0.091 | Alpha 1 adrenoreceptor agonist | |||
| 0.08 | 0.012 | 0.08 | Potassium channel Kv1.3 blocker | |||
| 0.135 | 0.067 | 0.135 | Tubulin antagonist | |||
| 0.254 | 0.189 | 0.254 | DNA directed DNA polymerase inhibitor | |||
| 0.126 | 0.062 | 0.126 | Anesthetic local | |||
| 0.095 | 0.031 | 0.127 | CDC25A inhibitor | 0.127 0.017 CID_131770039 | CID_131770039 | |
| 0.179 | 0.115 | 0.179 | Free radical scavenger | |||
| 0.083 | 0.022 | 0.083 | Alpha 2 adrenoreceptor agonist | |||
| 0.078 | 0.019 | 0.078 | Beta 1 adrenoreceptor antagonist | |||
| 0.093 | 0.037 | 0.093 | Thioredoxin reductase inhibitor | |||
| 0.143 | 0.092 | 0.143 | Melanin inhibitor | |||
| 0.104 | 0.054 | 0.104 | Alpha adrenoreceptor antagonist | |||
| 0.105 | 0.055 | 0.105 | Estrogen receptor beta antagonist | |||
| 0.164 | 0.118 | 0.164 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.113 | 0.068 | 0.113 | Estrogen antagonist | |||
| 0.068 | 0.024 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.09 | 0.046 | 0.09 | Topoisomerase II alpha inhibitor | |||
| 0.123 | 0.08 | 0.123 | Vanilloid 1 agonist | |||
| 0.119 | 0.078 | 0.119 | Toll-Like receptor 2 antagonist | |||
| 0.142 | 0.102 | 0.142 | Nitric oxide antagonist | |||
| 0.112 | 0.074 | 0.112 | Topoisomerase II inhibitor | |||
| 0.112 | 0.075 | 0.112 | DNA polymerase I inhibitor | |||
| 0.164 | 0.127 | 0.164 | Aldehyde oxidase inhibitor | |||
| 0.059 | 0.025 | 0.059 | Beta 2 adrenoreceptor antagonist | |||
| 0.107 | 0.083 | 0.107 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.132 | 0.11 | 0.132 | Mcl-1 antagonist | |||
| 0.101 | 0.08 | 0.101 | Electron transport complex I inhibitor | |||
| 0.064 | 0.045 | 0.064 | CDC25B inhibitor | |||
| 0.141 | 0.125 | 0.141 | Neurotensin receptor agonist | |||
| 0.183 | 0.169 | 0.183 | Prostaglandin dehydrogenase inhibitor | |||
| 0.087 | 0.074 | 0.087 | 5-Lipoxygenase inhibitor | |||
| 0.148 | 0.137 | 0.148 | Insulin sensitizer | |||
| 0.101 | 0.09 | 0.101 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.069 | 0.059 | 0.069 | Alpha 1 adrenoreceptor antagonist | |||
| 0.124 | 0.116 | 0.124 | Adenylate cyclase stimulant | |||
| 0.107 | 0.103 | 0.107 | DNA repair enzyme inhibitor | |||
| 0.088 | 0.085 | 0.088 | Monophenol monooxygenase inhibitor | |||
| 0.061 | 0.06 | 0.061 | Alpha 1b adrenoreceptor antagonist | |||
| 0.05 | 0.049 | 0.05 | Dopamine uptake inhibitor | |||
| 0.026 | 0.027 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.004 CID_131770039 | CID_131770039 | |
| 0.02 | 0.021 | 0.042 | Dopamine D1 agonist | 0.042 0.005 CID_131770039 | CID_131770039 | |
| 0.131 | 0.132 | 0.14 | Hepatoprotectant | 0.14 0.121 CID_131770039 | CID_131770039 | |
| 0.13 | 0.132 | 0.286 | Platelet adhesion inhibitor | 0.286 0.038 CID_131770039 | CID_131770039 | |
| 0.156 | 0.183 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.182 0.128 CID_131770039 | CID_131770039 | |
| 0.045 | 0.075 | 0.081 | HIV-1 integrase (3'-Processing) inhibitor | 0.081 0.033 CID_131770039 | CID_131770039 | |
| 0.024 | 0.062 | 0.116 | Dopamine D2 agonist | 0.116 0.009 CID_131770039 | CID_131770039 | |
| 0.109 | 0.151 | 0.338 | Angiogenesis stimulant | 0.338 0.036 CID_131770039 | CID_131770039 | |
| 0.106 | 0.15 | 0.241 | Dual specificity phosphatase 3 inhibitor | 0.241 0.043 CID_131770039 | CID_131770039 | |
| 0.038 | 0.086 | 0.069 | Dopamine agonist | 0.069 0.045 CID_131770039 | CID_131770039 | |
| 0.034 | 0.085 | 0.077 | HIV-1 integrase (Strand Transfer) inhibitor | 0.077 0.032 CID_131770039 | CID_131770039 | |
| 0.095 | 0.156 | 0.192 | Protein-tyrosine phosphatase inhibitor | 0.192 0.05 CID_131770039 | CID_131770039 | |
| 0.03 | 0.103 | 0.116 | Selectin antagonist | 0.116 0.023 CID_131770039 | CID_131770039 | |
| 0.029 | 0.136 | 0.084 | Factor IXa inhibitor | 0.084 0.014 CID_131770039 | CID_131770039 | |
| 0.132 | 0.255 | 0.211 | Cholesterol antagonist | 0.211 0.155 CID_131770039 | CID_131770039 | |
| 0.069 | 0.194 | 0.116 | Acetylcholine release stimulant | 0.116 0.055 CID_131770039 | CID_131770039 | |
| 0.03 | 0.182 | 0.078 | Cathepsin G inhibitor | 0.078 0.045 CID_131770039 | CID_131770039 | |
| 0.141 | 0.315 | 0.308 | Antibacterial | 0.308 0.13 CID_131770039 | CID_131770039 | |
| 0.014 | 0.277 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 CID_131770039 | CID_131770039 | |
| 0.041 | 0.367 | 0.115 | Cell wall synthesis inhibitor | 0.115 0.107 CID_131770039 | CID_131770039 | |
| 0.003 | 0.52 | 0.203 | Cholecystokinin A agonist | 0.203 0.003 CID_131770039 | CID_131770039 | |
| 0.003 | 0.54 | 0.242 | Cholecystokinin agonist | 0.242 0.003 CID_131770039 | CID_131770039 | |
| 0.018 | 0.557 | 0.138 | Multidrug resistance-associated protein 1 inhibitor | 0.138 0.032 CID_131770039 | CID_131770039 | |
| 0.009 | 0.594 | 0.402 | Cholecystokinin B agonist | 0.402 0.003 CID_131770039 | CID_131770039 | |
| 0.024 | 0.675 | 0.217 | Angiogenesis inhibitor | 0.217 0.151 CID_131770039 | CID_131770039 | |
| 0.008 | 0.752 | 0.196 | Anticoagulant | 0.196 0.055 CID_131770039 | CID_131770039 | |
| 0.004 | 0.774 | 0.052 | NMDA 2B receptor antagonist | 0.052 0.039 CID_131770039 | CID_131770039 | |
| 0.003 | 0.813 | 0.091 | Cholecystokinin A antagonist | 0.091 0.01 CID_131770039 | CID_131770039 | |
| 0.003 | 0.848 | 0.057 | Cholecystokinin antagonist | 0.057 0.021 CID_131770039 | CID_131770039 | |
| 0.002 | 0.848 | 0.037 | Cholecystokinin B antagonist | 0.037 0.016 CID_131770039 | CID_131770039 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |